Structure |
Chemical Name |
CAS |
MF |
![Mono-POC Tenofovir 6-Isopropyl CarbaMate](/CAS/GIF/1244022-56-7.gif) |
Mono-POC Tenofovir 6-Isopropyl CarbaMate |
1244022-56-7 |
C18H28N5O9P |
![N-Methyl Iso Desloratadine](/CAS/GIF/183198-48-3.gif) |
N-Methyl Iso Desloratadine |
183198-48-3 |
C20H21ClN2 |
![酒石酸イソプロピルエステル](/CAS/GIF/116601-09-3.gif) |
酒石酸イソプロピルエステル |
116601-09-3 |
C7H12O6 |
![Rivaroxaban Impurity 11](/CAS/20180808/GIF/1411775-06-8.gif) |
Rivaroxaban Impurity 11 |
1411775-06-8 |
C14H17N3O4 |
![(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl propionate](/CAS/20200401/GIF/CB83129539.gif) |
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl propionate |
|
C25H35NO3 |
![Flomoxef Impurity 4](/) |
Flomoxef Impurity 4 |
|
|
![Nicardipine Impurity 5](/) |
Nicardipine Impurity 5 |
|
|
![11,11'-(PIPERAZINE-1,4-DIYL)-BIS-8-CHLORO-5H-DIBENZE[B,E][1,4]-DIAZEPINE](/CAS/GIF/263366-81-0.gif) |
11,11'-(PIPERAZINE-1,4-DIYL)-BIS-8-CHLORO-5H-DIBENZE[B,E][1,4]-DIAZEPINE |
263366-81-0 |
C30H24Cl2N6 |
![Sacubitril Impurity 7](/CAS/20180713/GIF/149709-44-4.gif) |
Sacubitril Impurity 7 |
149709-44-4 |
C22H25NO5 |
![Valsartan Impurity 5](/CAS/20180703/GIF/1266616-11-8.gif) |
Valsartan Impurity 5 |
1266616-11-8 |
C18H21N5 |
![Milnacipran Impurity 4](/CAS/20210111/GIF/1353644-49-1.gif) |
Milnacipran Impurity 4 |
1353644-49-1 |
C15H21NO2 |
![2-アミノ-2-(4-ヘプチルフェネチル)-1,3-プロパンジオール](/CAS/20180808/GIF/745767-97-9.gif) |
2-アミノ-2-(4-ヘプチルフェネチル)-1,3-プロパンジオール |
745767-97-9 |
C18H31NO2 |
![Tenofovir Fumarate](/CAS/20180906/GIF/1246812-23-6.gif) |
Tenofovir Fumarate |
1246812-23-6 |
C21H34N5O9P |
![Prucalopride Impurity C](/CAS/20210111/GIF/1599434-55-5.gif) |
Prucalopride Impurity C |
1599434-55-5 |
C17H24ClN3O3 |
![1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20200401/GIF/2205053-60-5.gif) |
1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
2205053-60-5 |
C21H24FN3O4 |
![Brexpiprazole N-Oxide](/CAS/20200515/GIF/1191900-58-9.gif) |
Brexpiprazole N-Oxide |
1191900-58-9 |
C25H27N3O3S |
![2,6-Dibenzyloxyacetophenone](/CAS/20180906/GIF/3886-19-9.gif) |
2,6-Dibenzyloxyacetophenone |
3886-19-9 |
C22H20O3 |
![6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル](/CAS/20180703/GIF/1059630-08-8.gif) |
6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル |
1059630-08-8 |
C14H17BrN2O2 |
![diphenhydramine impurity](/CAS/20180703/GIF/CB83144868.gif) |
diphenhydramine impurity |
|
C17H21NO |
![1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide](/CAS/20180703/GIF/CB83146796.gif) |
1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide |
|
C18H23IN4S |
![2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid](/CAS/20180703/GIF/1657014-33-9.gif) |
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid |
1657014-33-9 |
C16H16N2O3S |
![vildagliptin Impurity O](/CAS/20200611/GIF/2253194-12-4.gif) |
vildagliptin Impurity O |
2253194-12-4 |
C12H18N4O2 |
![methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/38990-17-9.gif) |
methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
38990-17-9 |
C21H26N2O3 |
![Canagliflozin Impurity 17](/CAS/20210111/GIF/1951467-28-9.gif) |
Canagliflozin Impurity 17 |
1951467-28-9 |
C24H23FO6S |
![Canagliflozin Impurity 22](/) |
Canagliflozin Impurity 22 |
|
|
![Carfilzomib Impurity 3](/) |
Carfilzomib Impurity 3 |
|
|
![Dolutegravir Impurity 4](/) |
Dolutegravir Impurity 4 |
|
|
![Febuxostat Impurity 20](/) |
Febuxostat Impurity 20 |
|
|
![Lenvatinib Impurity 1](/) |
Lenvatinib Impurity 1 |
|
|
![methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20211123/GIF/83508-82-1.gif) |
methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
83508-82-1 |
C21H26N2O3 |
![4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester](/CAS/20180703/GIF/1941177-45-2.gif) |
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester |
1941177-45-2 |
C29H37N7O3 |
![Cabozantinib impurity 1](/CAS/20200611/GIF/748707-58-6.gif) |
Cabozantinib impurity 1 |
748707-58-6 |
C17H16N2O3 |
![Amlodipine Impurity 19](/CAS/20180703/GIF/CB83159169.gif) |
Amlodipine Impurity 19 |
|
C26H31ClN2O8S |
![Amlodipine Impurity 9](/CAS/20180703/GIF/CB83159174.gif) |
Amlodipine Impurity 9 |
90445-05-9 |
C26H31ClN2O8S |
![Clopidogrel Impurity 7](/CAS/20180601/GIF/444728-13-6.gif) |
Clopidogrel Impurity 7 |
444728-13-6 |
C15H15ClN2OS |
![Rivaroxaban Impurity 36](/CAS/20210305/GIF/1770812-39-9.gif) |
Rivaroxaban Impurity 36 |
1770812-39-9 |
C19H17Cl2N3O5S |
![(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate](/CAS/20180601/GIF/1111177-24-2.gif) |
(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate |
1111177-24-2 |
C20H23N5O2 |
![Clopidogrel Impurity C](/CAS/20180601/GIF/1346605-15-9.gif) |
Clopidogrel Impurity C |
1346605-15-9 |
C16H18ClNO2S |
![Nilotinib genotoxic impurity 2](/CAS/20180906/GIF/1157857-29-8.gif) |
Nilotinib genotoxic impurity 2 |
1157857-29-8 |
C19H15F3N4O3 |
![N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン](/CAS/20180808/GIF/1453221-45-8.gif) |
N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン |
1453221-45-8 |
C35H41F6N3O6 |
![Gliclazide Impurity E](/) |
Gliclazide Impurity E |
|
|
![Ethyl 1-butanesulfonate](/CAS/20180601/GIF/2374-68-7.gif) |
Ethyl 1-butanesulfonate |
2374-68-7 |
C6H14O3S |
![OLANEXIDINE intermediate](/CAS/20180808/GIF/60852-95-1.gif) |
OLANEXIDINE intermediate |
60852-95-1 |
C10H20N4 |
![1H-Isoindole, octahydro-, trans-](/CAS/20180601/GIF/10479-63-7.gif) |
1H-Isoindole, octahydro-, trans- |
10479-63-7 |
C8H15N |
![1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI)](/CAS/20180601/GIF/155272-03-0.gif) |
1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |
155272-03-0 |
C18H20N4O4 |
![Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)-](/CAS/20180601/GIF/181289-34-9.gif) |
Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)- |
181289-34-9 |
C9H17NO3 |
![4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate](/CAS/20180601/GIF/65141-48-2.gif) |
4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate |
65141-48-2 |
C8H10N4O7 |
![2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE](/CAS/GIF/91219-90-8.gif) |
2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE |
91219-90-8 |
C11H15NO3 |
![4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE](/CAS/GIF/112809-52-6.gif) |
4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE |
112809-52-6 |
C17H11N5 |
![Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)-](/CAS/20180601/GIF/93239-37-3.gif) |
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
93239-37-3 |
C24H30O5 |
![Tadalafil EP impurity E](/) |
Tadalafil EP impurity E |
|
|
![4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine](/CAS/20200611/GIF/134965-85-8.gif) |
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine |
134965-85-8 |
C12H7ClN6 |
![(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile](/CAS/GIF/914070-99-8.gif) |
(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile |
914070-99-8 |
C7H11N3O |
![1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea](/CAS/20180601/GIF/1388858-78-3.gif) |
1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
1388858-78-3 |
C19H23FN2O2 |
![Isavuconazole Impurity 48](/) |
Isavuconazole Impurity 48 |
|
|
![5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-hydroxyquinolin-2(1H)-one)](/) |
5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-hydroxyquinolin-2(1H)-one) |
|
|
![2-(4-(2-(4-(1-(2-methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid](/CAS/20181212/GIF/CB39996369.gif) |
2-(4-(2-(4-(1-(2-methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid |
|
C27H35N3O3 |
![Tafluprost Impurity 19](/) |
Tafluprost Impurity 19 |
|
|
![Rosuvastatin Impurity 162](/) |
Rosuvastatin Impurity 162 |
|
|
![Rosuvastatin Impurity 151](/) |
Rosuvastatin Impurity 151 |
|
|
![Rosuvastatin Impurity 148](/) |
Rosuvastatin Impurity 148 |
|
|
![フロセミドアシルグルクロニド](/CAS/GIF/72967-59-0.gif) |
フロセミドアシルグルクロニド |
72967-59-0 |
C18H19ClN2O11S |
![Digoxin Impurity 1](/) |
Digoxin Impurity 1 |
|
|
![(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/769908-13-6.gif) |
(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
769908-13-6 |
C25H24FNO4 |
![(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate](/CAS/20180808/GIF/261506-24-5.gif) |
(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
261506-24-5 |
C34H49F5O4S |
![1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid](/CAS2/GIF/1163685-30-0.gif) |
1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
1163685-30-0 |
C14H11N3O3 |
![O-Desethyl Candesartan Cilexetil](/CAS/GIF/869631-11-8.gif) |
O-Desethyl Candesartan Cilexetil |
869631-11-8 |
C31H30N6O6 |
![Epi Lovastatin](/CAS/GIF/79952-44-6.gif) |
Epi Lovastatin |
79952-44-6 |
C24H36O5 |
![Hydroxy Brimonidine](/CAS/GIF/1216379-05-3.gif) |
Hydroxy Brimonidine |
1216379-05-3 |
C11H12BrN5O |
![7-メトキシ-3,4-ジヒドロキノリン-2(1H)-オン](/CAS2/GIF/22246-17-9.gif) |
7-メトキシ-3,4-ジヒドロキノリン-2(1H)-オン |
22246-17-9 |
C10H11NO2 |
![N-ベンジル-1-(4-メトキシフェニル)プロパン-2-アミン塩酸塩](/CAS2/GIF/1049695-95-5.gif) |
N-ベンジル-1-(4-メトキシフェニル)プロパン-2-アミン塩酸塩 |
1049695-95-5 |
C17H21NO.HCl |
![モンテルカストメチルケトン](/CAS/GIF/937275-23-5.gif) |
モンテルカストメチルケトン |
937275-23-5 |
C34H32ClNO3S |
![Propyl Itraconazole](/CAS/GIF/74855-91-7.gif) |
Propyl Itraconazole |
74855-91-7 |
C34H36Cl2N8O4 |
![3-methyleneisobenzofuran-1(3H)-one](/CAS2/GIF/3453-63-2.gif) |
3-methyleneisobenzofuran-1(3H)-one |
3453-63-2 |
C9H6O2 |
![Irbesartan impurity A](/CAS/20200331/GIF/CB62514437.gif) |
Irbesartan impurity A |
|
C25H28N6O |
![(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine](/CAS/20180713/GIF/223673-35-6.gif) |
(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine |
223673-35-6 |
C21H26N2O5 |
![Azelastine N-Oxide](/CAS/GIF/640279-88-5.gif) |
Azelastine N-Oxide |
640279-88-5 |
C22H24ClN3O2 |
![4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド](/CAS/GIF/1193725-75-5.gif) |
4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド |
1193725-75-5 |
C19H15ClN2O2 |
![16α,17,21-Trihydroxy-pregna-1,4-diene-3,11,20-trione](/CAS/GIF/3754-05-0.gif) |
16α,17,21-Trihydroxy-pregna-1,4-diene-3,11,20-trione |
3754-05-0 |
C21H26O6 |
![4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity](/CAS/GIF/116182-43-5.gif) |
4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity |
116182-43-5 |
C26H43NaO9 |
![N-(3-エチニル-4-メチルフェニル)-6,7-ビス(2-メトキシエトキシ)キナゾリン-4-アミン](/CAS/20140608/GIF/CB62544810.gif) |
N-(3-エチニル-4-メチルフェニル)-6,7-ビス(2-メトキシエトキシ)キナゾリン-4-アミン |
1346601-52-2 |
C23H25N3O4 |
![5-[[(4-フルオロフェニル)メチル]アミノ]-1,3-ジヒドロ-2H-イミダゾ[4,5-B]ピリジン-2-オン](/CAS/GIF/951624-49-0.gif) |
5-[[(4-フルオロフェニル)メチル]アミノ]-1,3-ジヒドロ-2H-イミダゾ[4,5-B]ピリジン-2-オン |
951624-49-0 |
C13H11FN4O |
![ペリンドプリラットラクタムB](/CAS/GIF/130061-28-8.gif) |
ペリンドプリラットラクタムB |
130061-28-8 |
C17H26N2O4 |
![シュードモン酸Dナトリウム](/CAS/GIF/85178-60-5.gif) |
シュードモン酸Dナトリウム |
85178-60-5 |
C26H41NaO9 |
![N-DesMethyl SuMatriptan](/CAS/GIF/88919-51-1.gif) |
N-DesMethyl SuMatriptan |
88919-51-1 |
C13H19N3O2S |
![1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one](/CAS/20200401/GIF/220182-11-6.gif) |
1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one |
220182-11-6 |
C10H20N4O |
![Ropivacaine EP Impurity D](/CAS/20200611/GIF/98626-59-6.gif) |
Ropivacaine EP Impurity D |
98626-59-6 |
C16H24N2O |
![Bendamustine Impurity 16](/CAS/20200611/GIF/914626-65-6.gif) |
Bendamustine Impurity 16 |
914626-65-6 |
C19H18N6O4 |
![(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride](/CAS/20180601/GIF/959392-22-4.gif) |
(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride |
959392-22-4 |
C18H19NOS |
![tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate](/) |
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](/CAS/20210305/GIF/2459302-85-1.gif) |
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
![(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium)](/CAS/20211123/GIF/96946-55-3.gif) |
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
![Glycine, N-(2-aminobenzoyl)-, ethyl ester](/CAS/20210305/GIF/5973-34-2.gif) |
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
![3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン](/CAS/GIF/54528-00-6.gif) |
3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン |
54528-00-6 |
C7H14N2 |
![(S)-Methyl 2-aminobutanoate](/CAS/GIF/15399-22-1.gif) |
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
![(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one](/) |
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
![(3R)-3α,4α-(1,3-ジベンジルウレイレン)テトラヒドロチオフェン-5-オン](/CAS/GIF/28092-52-6.gif) |
(3R)-3α,4α-(1,3-ジベンジルウレイレン)テトラヒドロチオフェン-5-オン |
28092-52-6 |
C19H18N2O2S |
![(2S)-2-ピロリジンカルボン酸メチル](/CAS/GIF/2577-48-2.gif) |
(2S)-2-ピロリジンカルボン酸メチル |
2577-48-2 |
C6H11NO2 |
![sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate](/) |
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
![2,4,6-トリプロピル-1,3,5-トリオキサン](/CAS/GIF/2396-43-2.gif) |
2,4,6-トリプロピル-1,3,5-トリオキサン |
2396-43-2 |
C12H24O3 |